Neurophysiological predictors of non-response to rTMS in depression

scientific article

Neurophysiological predictors of non-response to rTMS in depression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BRS.2011.12.003
P698PubMed publication ID22410477
P5875ResearchGate publication ID221696331

P50authorPaul B. FitzgeraldQ37838866
Wilhelmus DrinkenburgQ39393318
Martijn ArnsQ51982678
P2093author name stringJ Leon Kenemans
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectneurophysiologyQ660910
P304page(s)569-76
P577publication date2012-10-01
P1433published inBrain StimulationQ15716729
P1476titleNeurophysiological predictors of non-response to rTMS in depression
P478volume5

Reverse relations

cites work (P2860)
Q38064097A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression
Q89637854An electroencephalographic signature predicts antidepressant response in major depression
Q30433209Ant Colony Optimization Based Feature Selection Method for QEEG Data Classification
Q90344827Baseline Difference in Quantitative Electroencephalography Variables Between Responders and Non-Responders to Low-Frequency Repetitive Transcranial Magnetic Stimulation in Depression
Q37325262Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation.
Q58762794Bilateral Transcranial Magnetic Stimulation on DLPFC Changes Resting State Networks and Cognitive Function in Patients With Bipolar Depression
Q38864824Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
Q27027184Clinically Meaningful Efficacy and Acceptability of Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Primary Major Depression: A Meta-Analysis of Randomized, Double-Blind and Sham-Controlled Trials
Q48403134Combining Neurophysiological and Functional Neuroimaging Biomarkers to Predict rTMS Non-Response in Depression
Q48068505EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study
Q38154919EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response
Q30204494Effects of physical exercise on individual resting state EEG alpha peak frequency
Q34324317Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials
Q57033193Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis
Q46329921Feature Selection and Classification of Electroencephalographic Signals: An Artificial Neural Network and Genetic Algorithm Based Approach
Q100737261Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography
Q33692400Individual Alpha Peak Frequency in Ice Hockey Shooting Performance
Q26823991Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
Q61448877Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical Data
Q30994290NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW.
Q41451392Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG Cordance
Q58697841Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression
Q34415486Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or ritux
Q90428157Precision non-implantable neuromodulation therapies: a perspective for the depressed brain
Q48317822QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Q58721391QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
Q34341099Repetitive transcranial magnetic stimulation (rTMS) for obsessive–compulsive disorder (OCD): An exploratory meta-analysis of randomized and sham-controlled trials
Q34333771Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials
Q30825123The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.
Q36164946The effects of QEEG-informed neurofeedback in ADHD: an open-label pilot study
Q90344570Trends of Repetitive Transcranial Magnetic Stimulation From 2009 to 2018: A Bibliometric Analysis
Q36855260Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression

Search more.